Sentence: A significant response to a combination of trastuzumab and vinorelbine in HER2-negative metastatic breast cancer with HER2 V777L mutation .
Drug combination annotation:
[{'class': 'POS', 'spans': ['trastuzumab', 'vinorelbine'], 'is_context_needed': False}]